TABLE 1.
Selected human genetic associations with fungal susceptibility discussed in this article
| Gene | Immunological phenotype | Associated disease |
|---|---|---|
| Dectin-1 | Dimunition of cytokine responses | Chronic mucocutaneous candidiasis, vulvovaginal candidiasis, onychomycosis, and intra-abdominal Candida |
| CARD9 | Dimunition of cytokine responsesDefective neutrophil chemotaxis | Disseminated candidiasis |
| TLR1 | Decreased IL-1β, IL-6, and IL-18 | Candidemia |
| TLR2 | Decreased IFN-γ and IL-8 | Candidemia |
| TLR3 | Reduced activation of NF-κB and decreased IFN-γ | Cutaneous candidiasis |
| NALP3 | Decreased IL-1β? | Candidiasis-mediated vestibulitis |
| MDA5 | Decreased type I IFNs | Systemic candidiasis |
| STAT1 | Decreased IL-17 production, elevated cell response to IFNs, IFN-γ,s and IL-27Defective IL-12R and IL-23R signaling | Chronic mucocutaneous candidiasis, coccidioidomycosis, histoplasmosis |
| STAT3 | Defective Th17 polarization, decreased IL-17/IL-22-expressing T cells, decreased IL-17-induced antimicrobial peptides | Chronic mucocutaneous candidiasis, coccidioidomycosis, histoplasmosis, cryptococcosis, aspergillosis, nail dermatophytosis |
| Autoimmune regulator | Neutralizing antibodies to IL-17 and IL-22 | Chronic mucocutaneous candidiasis |
| IL-17/IL-17R | Lack of IL-17 cellular responses | Chronic mucocutaneous candidiasis |
| IL-12RA | Impaired IL-12 and IL-23-mediated expression of IFN-γ | Coccidioidomycosis, paracoccidioidomycosis, histoplasmosis, cryptococcosis |